NORTHVALE, N.J., May 24, 2010 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today the acquisition of a currently approved Abbreviated New Drug ...
Impax Laboratories said today it has agreed to acquire a portfolio that includes 18 generic drugs from Teva Pharmaceutical Industries and affiliates of Allergan for $586 million. The portfolio being ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback